• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cell and Gene Therapy Catapult appoints three directors to the board

Cell and Gene Therapy Catapult appoints three directors to the board

March 7, 2016
CenterWatch Staff

The Cell and Gene Therapy Catapult, a U.K. organization dedicated to the growth of the U.K. cell and gene therapy industry by bridging the gap between scientific research and commercialization, has announced the appointment of three new non-executive directors to its board. 

The new appointments are:

  •             Professor Fiona Watt
  •             Dr. Susan Foden
  •             Dr. Steven Chatfield 

Prof Fiona Watt has spent 20 years at the CRUK London Research Institute and helped to establish the CRUK Cambridge Research Institute and the Wellcome Trust Centre for Stem Cell Research in Cambridge. In 2012 she moved to King’s College London, where she leads the Centre for Stem Cells and Regenerative Medicine. She is internationally recognized for her work on epidermal stem cells and their interactions and leads the UK Human Induced Pluripotent Stem Cell Initiative. 

Dr. Susan Foden has over 15 years’ experience as a non-executive director in life science companies in the biotechnology and healthcare field. She currently holds a number of non-executive positions including British Technology Group, Vectura, Evgen Pharma and BerGenBio. Susan has a background in science, corporate and academic partnerships and venture capital. Previous roles include CEO of Cancer Research Campaign Technology (now Cancer Research Technology) and investor director with Merlin Biosciences. 

Dr. Steven Chatfield brings more than 35 years’ experience in the field of research and development within the biopharmaceutical industry. His previous roles include executive positions at the Health Protection Agency, Emergent BioSolutions, Microscience, Medeva, Evans Medical and Wellcome Biotechnology with a focus on developing novel vaccines and immunotherapy products. 

Together they bring a wealth of experience from academia, and industry to the board. They join Nick Higgins, Professors Marc Turner and Michael Whitaker, and Executive Directors Matthew Durdy (chief business officer), Dr. Stephen Ward (chief operating officer), Professor Johan Hyllner (chief scientific officer), Dr. Natalie Mount (chief clinical officer), Chairman Dr. John Brown CBE, FRSE and CEO Keith Thompson.  

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing